Jacksonville Research Center Contributes to Novel Cholesterol-Lowering Therapy
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA met June 9th and 10th and recommended two products using a novel therapy for lowering the amount of low density lipoprotein (LDL) cholesterol in the blood.